Regeneron Pharmaceuticals, Inc. is rated a long-term Buy, but I expect near-term sideways trading due to limited new catalysts. Declining Eylea/Eylea HD revenues are largely offset by strong Dupixent ...

The BlackRock Enhanced Global Dividend Trust (BOE) is a closed-end fund that aims to provide investors with a high level of current income. As the fund primarily seeks to achieve its goal by using a ...